JPWO2020041498A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020041498A5 JPWO2020041498A5 JP2021509223A JP2021509223A JPWO2020041498A5 JP WO2020041498 A5 JPWO2020041498 A5 JP WO2020041498A5 JP 2021509223 A JP2021509223 A JP 2021509223A JP 2021509223 A JP2021509223 A JP 2021509223A JP WO2020041498 A5 JPWO2020041498 A5 JP WO2020041498A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- aav
- gpr108
- seq
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 54
- 101001070470 Homo sapiens Protein GPR108 Proteins 0.000 claims description 33
- 102100034142 Protein GPR108 Human genes 0.000 claims description 33
- 229920001184 polypeptide Polymers 0.000 claims description 33
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 33
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 14
- 230000026683 transduction Effects 0.000 claims description 14
- 238000010361 transduction Methods 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 12
- 229940124597 therapeutic agent Drugs 0.000 claims description 12
- 210000000234 capsid Anatomy 0.000 claims description 10
- 241000702421 Dependoparvovirus Species 0.000 claims description 8
- 230000001419 dependent effect Effects 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 241001655883 Adeno-associated virus - 1 Species 0.000 claims description 5
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 5
- 241000202702 Adeno-associated virus - 3 Species 0.000 claims description 5
- 241000580270 Adeno-associated virus - 4 Species 0.000 claims description 5
- 241001164823 Adeno-associated virus - 7 Species 0.000 claims description 5
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- 241001634120 Adeno-associated virus - 5 Species 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 108091023037 Aptamer Proteins 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 108091030071 RNAI Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862720859P | 2018-08-21 | 2018-08-21 | |
| US62/720,859 | 2018-08-21 | ||
| PCT/US2019/047546 WO2020041498A1 (en) | 2018-08-21 | 2019-08-21 | Compositions and methods for modulating transduction efficiency of adeno-associated viruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533795A JP2021533795A (ja) | 2021-12-09 |
| JPWO2020041498A5 true JPWO2020041498A5 (enExample) | 2022-07-25 |
| JP7451497B2 JP7451497B2 (ja) | 2024-03-18 |
Family
ID=69591093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021509223A Active JP7451497B2 (ja) | 2018-08-21 | 2019-08-21 | アデノ随伴ウイルスの形質導入効率を調節するための組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12195745B2 (enExample) |
| EP (1) | EP3841109A4 (enExample) |
| JP (1) | JP7451497B2 (enExample) |
| AU (1) | AU2019325332B2 (enExample) |
| WO (1) | WO2020041498A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020022858A2 (pt) | 2018-05-11 | 2021-02-23 | Massachusetts Eye And Ear Infirmary | tropismo específico hepático de vírus adeno-associado |
| EP4087391A1 (en) | 2020-04-09 | 2022-11-16 | University of Sheffield | Gene therapy treatment |
| WO2022103826A1 (en) * | 2020-11-10 | 2022-05-19 | The Children's Hospital Of Philadelphia | Compositons and methods for in vivo gene transfer |
| GB202215198D0 (en) | 2022-10-14 | 2022-11-30 | Univ Sheffield | Gene therapy treatment |
| WO2025114699A1 (en) | 2023-11-30 | 2025-06-05 | Cytomos Limited | Cell selection |
| WO2025188755A1 (en) | 2024-03-04 | 2025-09-12 | Kate Therapeutics, Inc. | Adeno-associated virus compositions for the treatment of duchenne muscular dystrophy |
| WO2025226841A1 (en) | 2024-04-24 | 2025-10-30 | Kate Therapeutics, Inc. | Gene therapy approach for treating disorders associated with tnnt2 |
| WO2025226842A1 (en) | 2024-04-24 | 2025-10-30 | Kate Therapeutics, Inc. | Expression control by drg-expressed mirnas |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6855314B1 (en) * | 2000-03-22 | 2005-02-15 | The United States Of America As Represented By The Department Of Health And Human Services | AAV5 vector for transducing brain cells and lung cells |
| EP1572893B1 (en) | 2001-11-09 | 2009-01-07 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES | Production of adeno-associated virus in insect cells |
| AU2003295312B2 (en) * | 2002-05-01 | 2008-08-14 | University Of Florida Research Foundation, Inc. | Improved rAAV expression systems for genetic modification of specific capsid proteins |
| US20060166363A1 (en) * | 2004-01-27 | 2006-07-27 | Sergei Zolotukhin | Modified baculovirus expression system for production of pseudotyped rAAV vector |
| EP3409296A1 (en) * | 2005-04-07 | 2018-12-05 | The Trustees of the University of Pennsylvania | Method of increasing the function of an aav vector |
| DK2954051T3 (da) * | 2013-02-08 | 2019-07-08 | Univ Pennsylvania | Modificeret kapsid til genoverførsel til behandling af nethinden |
| RU2738421C2 (ru) * | 2014-10-21 | 2020-12-14 | Юниверсити Оф Массачусетс | Варианты рекомбинантных aav и их применения |
| US10081659B2 (en) * | 2015-04-06 | 2018-09-25 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Adeno-associated vectors for enhanced transduction and reduced immunogenicity |
| US10633662B2 (en) | 2015-11-10 | 2020-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for modulating AAV infection |
| EP3448874A4 (en) * | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| MX2018013463A (es) * | 2016-05-13 | 2019-07-04 | 4D Molecular Therapeutics Inc | Capsides variantes de virus adenoasociados y metodos de uso de las mismas. |
| EP3491008A2 (en) | 2016-07-26 | 2019-06-05 | BioMarin Pharmaceutical Inc. | Novel adeno-associated virus capsid proteins |
| US11698377B2 (en) * | 2016-08-15 | 2023-07-11 | Genzyme Corporation | Methods for detecting AAV |
| WO2018119330A2 (en) * | 2016-12-22 | 2018-06-28 | Oregon Health & Science University | Adeno associated viral vectors |
| US20210292373A1 (en) | 2018-07-10 | 2021-09-23 | University Of Florida Research Foundation, Incorporated | Aav vp1u chimeras |
| TW202532428A (zh) * | 2019-04-26 | 2025-08-16 | 美商愛德維仁生物科技公司 | 用於玻璃體內遞送之變異體aav蛋白殼 |
-
2019
- 2019-08-21 JP JP2021509223A patent/JP7451497B2/ja active Active
- 2019-08-21 US US17/269,955 patent/US12195745B2/en active Active
- 2019-08-21 AU AU2019325332A patent/AU2019325332B2/en active Active
- 2019-08-21 WO PCT/US2019/047546 patent/WO2020041498A1/en not_active Ceased
- 2019-08-21 EP EP19851371.5A patent/EP3841109A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022190081A5 (enExample) | ||
| US11015189B2 (en) | AAV capsid proteins for nucleic acid transfer | |
| CN109715650B (zh) | 新颖腺相关病毒衣壳蛋白 | |
| IL317938A (en) | Recombinant viral vectors with altered tropism and their uses for the targeted introduction of genetic material into human cells | |
| JP2020019772A5 (enExample) | ||
| KR20250025387A (ko) | Aav 캡시드 변이체 및 이의 용도 | |
| AU2018323049B2 (en) | Adeno-associated virus (AAV) with modified phospholipase domain | |
| JP2020519284A5 (enExample) | ||
| JP2025004107A (ja) | ガラクトース血症の処置のための遺伝子治療 | |
| TW202246516A (zh) | 病毒蛋白之控制表現 | |
| JP2020519294A5 (enExample) | ||
| JPWO2020041498A5 (enExample) | ||
| JP2025517628A (ja) | 新規の組換えaav vp2融合ポリペプチド | |
| JPWO2021053222A5 (enExample) | ||
| CN120548368A (zh) | 用于正确包装重复元件的腺相关病毒载体 | |
| JPWO2019173538A5 (enExample) | ||
| JPWO2020168222A5 (enExample) | ||
| JPWO2020186150A5 (enExample) | ||
| JPWO2020159970A5 (enExample) | ||
| CA3138274A1 (en) | Intrathecal and intravenous combination gene therapy for the treatment of infantile batten disease | |
| RU2024111148A (ru) | Вирусные частицы, перенацеленные на скелетные мышцы | |
| JPWO2022235933A5 (enExample) | ||
| HK40048783A (en) | New avv capsid proteins for nucleic acid transfer | |
| JPWO2021195218A5 (enExample) | ||
| RU2021133286A (ru) | Модифицированные вирусные частицы и пути их применения |